Prophylactic and therapeutic uses of probiotics: A review

Journal of the American Dietetic Association

Volumn 101, Issue 2, 2001, Pages 229-241

  Kopp Hoolihan, Lori ^a  

^a Dairy Council of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BIFIDOBACTERIUM; BIOAVAILABILITY; DIGESTIVE FUNCTION; DIGESTIVE SYSTEM; HEALTH FOOD; HUMAN; HYPERSENSITIVITY; IMMUNE SYSTEM; LACTOBACILLUS; LACTOSE INTOLERANCE; MICROBIOLOGY; NEOPLASM; PHYSIOLOGY; REVIEW; SAFETY; TIME; TREATMENT OUTCOME;

BIFIDOBACTERIUM; BIOLOGICAL AVAILABILITY; DIGESTIVE PHYSIOLOGY; DIGESTIVE SYSTEM; HEALTH FOOD; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; LACTOBACILLUS; LACTOSE INTOLERANCE; NEOPLASMS; PROBIOTICS; SAFETY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0142067866     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(01)00060-8     Document Type: Review

References (76)

1. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69(suppl):1052S-7S.
2. Lilly DM, Stillwell RH. Probiotics: growth promoting factors produced by microorganisms. Science 1965;147:747-748.
3. Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999;39(1):1-126.
4. De Vuyst L, Vandamme EJ. Antimicrobial potential of lactic acid bacteria. In: De Vuyst L, Vandamme EL, eds. Bacteriocins of lactic acid bacteria. Glasgow, United Kingdom: Blackie Academic and Professional; 1994:91-142.
5. Dodd HM, Gasson MJ. Bacteriocins of lactic acid bacteria. In: Gasson MJ, de Vos WM, eds. Genetics and biotechnology of lactic acid bacteria. Glasgow, United Kingdom: Blackie Academic and Professional; 1994:211-51.
6. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000:78(1):80-8.
7. Langhendries JP, Detry J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ, Secretin MC, Senterre J. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 1995;21:177-81.
8. Fujiwara S, Hashiba H, Hirota T, Forstner JF. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol 1997;63;506-12.
9. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp. Strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-97.
10. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D 3 RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995;13:310-312.
11. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000:130(2S):396S-402S.
12. Simenhoff ML, Dunn SR, Zollner GP, Fitzpatrick ME, Emery SM, Sandine WE, Ayres JW. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 1996;22:92-96.
13. Nanji AA, Khettry U, Sadrzadeh SMH. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 1994;205:243-7.
14. Orrhage K, Brismar B, Nord CE. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microbiol Ecol Health Dis 1994;7:17.
15. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997;11:853-8.
16. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-lsoviita L, Nikkari S, Oksanen T, Porsti I, Salminen E. Prevention of travelers diarrhea by Lactobacillus GG. Ann Med 1990;22:53-56.
17. Gade J, Thorn P. Paraghurt for patients with irritable bowel syndrome. Scan J Prim Health Care 1989;7:23-26.
18. Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola AL. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990;22:57-59.
19. Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979;36:754-7.
20. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 2000;95:S11-13.
21. Hilton E, Kolakawski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. Journal of Travel Medicine 1997;4:41-43.
22. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S; Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H, Weizman Z. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30(1):54-60.
23. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000:95(1S):2S-4S.
24. Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol 2000:95(1S):19S-21S.
25. Nobaek S, Johansson ML, Molin G, Ahrn'e S, Jeppsson B, Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000:95(5):1231-8.
26. Kabir AMA, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997;41:49-55.
27. Aiba Y, Suzuki N, Kabir AMA, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pyloriby the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Amer J Gastroenterol 1998;93:2097-2101.
28. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corth'esy-Theulaz I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999;60(3):203-9.
29. Seki M, Igarashi T, Fukuda Y, Simamura S, Kaswashima T, Ogasa K. The effect of Bifidobacterium cultured milk on the "regularity" among an aged group. Nutr Foodstuff 1978;31:379-87.
30. Motta L, Blancato G, Scornavacca G, De Luca M, Vasquez E, Gismondo MR, Lo Bue A, Chisari G. Study on the activity of a therapeutic bacterial combination in intestinal motility disorders in the aged. Clin Ter 1991;138:27-35.
31. Bennet A, Eley KG. Intestinal pH and propulsion: an explanation of diarrhoea in lactase deficiency and laxation by lactulose. J Pharm Pharmacol 1976;28:192-5.
32. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol 2000:95(1S):16S-18S.
33. McCracken BJ, Gaskins HR. Probiotics and the immune system. In: Tannock GW, ed. Probiotics: A Critical Review. Norfolk, England: Horizon Scientific Press; 1999:85-111.
34. Marteau P, Rambaud J-C. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993;12:207.
35. Perdigon G, Alvarez S. Probiotics and the immune state. In: R Fuller, ed. Probiotics. The Scientific Basis. London: Chapman and Hall; 1992:145.
36. Tomioka H, Saito H. Lactic acid bacteria in the support of immuno-compromised hosts. In: BJB Wood, ed. The Lactic Acid Bacteria. Volume 1. The Lactic Acid Bacteria in Health and Disease. London: Elsevier Applied Science; 1992:263.
37. Pestka JJ. Food, diet, and gastrointestinal immune function. Adv Food Nutr Res 1993;37:1-66.
38. Sanders ME. Probiotics. Food Technology 1999;53(11):67-77.
39. De Simone C, Ciardi A, Grassi A, Lambert Gardini S, Tzantzoglou S, Trinchieri V, Moretti S, Jirillo E. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992;14:331-340.
40. Rajalakshmi R, Vanaji K. Chemical and biological evaluation of the effects of fermentation on the nutritive value of foods prepared from rice and grain. Br J Nutr 1967;21:467-73.
41. Shahani KM, Chandan RC. Nutritional and healthful aspects of cultured and culture-containing dairy foods. J Dairy Sci 1979;62:1685-94.
42. Deeth HC, Tomine AY. Yogurt: nutritive and therapeutic aspects. J Food Protect 1981;44:78-86.
43. Alm L. Effect of fermentation on B-vitamin content of milk in Sweden. J Dairy Sci 1982;65:353-9.
44. Friend BA, Shahani KM. Nutritional and therapeutic aspects of lactobacilli. J Appl Nutr 1984;36:125-53.
45. Rombeau JL, Kripke SA, Settle RG. Short-chain fatty acids. Production, absorption, metabolism and intestinal effects. In: Kritchesvsky D, ed. Dietary fiber: chemistry, physiology, and health effects. New York and London: Plenum Press; 1990:317-337.
46. Leavitt J, Barrett JC, Crawford BD, Tso POP. Butyric acid suppression on the in vitro neoplastic state of Syrian hamster cells. Nature 1978;271:262.
47. Mallett AK, Bearne CA, Rowland IR. The influence of incubation pH on the activity of rat and human gut flora enzymes. J Appl Bacteriol 1989;66:433-37.
48. nd ed. Wash DC: CRC Press; 2000:311.
49. Kilara A, Shahani KM. Lactase activity of cultured and acidified dairy products. J Dairy Sci 1975;59:2031-35.
50. Gilllland SE, Kim HS. Effect of viable starter culture bacteria in yogurt on lactose utilization in humans. J Dairy Sci 1984;67:1-6.
51. Kolars JC, Levitt MD, Aouji M, Savaiano DA. Yogurt - an autodigesting source of lactose. N Engl J Med 1984;310(1):1-3.
52. Marteau P, Fleurie B, Pochart P, Chastang C, Desjeux JF, Rambaud JC. Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans. Br J Nutr 1990;64:71-9.
53. Shermak MA, Saavedra JM, Jackson TL, Huang SS, Bayless TM, Perman JA. Effect of yogurt on symptoms and kinetics of hydrogen production in lactose-malabsorbing children. Am J Clin Nutr 1995;62:1003-6.
54. Martini MC, Kukielka D, Savaiano DA. Lactose digestion from yogurt: influence of a meal and additional lactose. Am J Clin Nutr 1991;53:1253-8.
55. Jiang T, Mustapham A, Savaiano DA. Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum. J Dairy Sci 1996;79:750-7.
56. Rao CV, Sanders ME, Indranie C, Simi B, Reddy BS. Prevention of indices of colon carcinogenesis by the probiotic Lactobacillus acidophilus NCFM™ in rats. Int J Oncol 1999;14:939-944.
57. Goldin BR, Gualtieri L, Moore RP. The effect of Lactobacillus GG on the initiation and promotion of dimethylhydrazine-induced intestinal tumors in the rat. Nutr Cancer 1996;25:197-204.
58. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5]quinoline, a food mutagen. Canc Res 1993;53:3914-18.
59. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 1992;49:125-9.
60. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Experim Allergy 1999;29:342-6.
61. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immun 1997;99:179-85.
62. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as a prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996;5:593-596.
63. Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as a prophylaxis for candidal vaginitis. Ann Intern Med 1992;116:353-357.
64. McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000;49(6):543-52.
65. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. The relationship of hydrogen peroxid-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 1992;79:369-73.
66. Taranto MP, Medici M, Perdigon G, Ruiz Holgado AP, Valdez GF. Evidence for hypocholesterolemic effect of Lactobacillus reuteriin hypercholesterolemic mice. J Dairy Sci 1998;81(9):2336-40.
67. Mohan JC, Arora R, Khalilullah M. Short-term hypolipidemic effects of oral Lactobacillus sporogenes therapy in patients with primary dyslipidemias. Indian Heart J 1990;42:361-64.
68. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000:54(4):288-9.
69. Nakamura Y, Yamamoto N, Sakai K, Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin-1-converting enzyme. J Dairy Sci 1995;78:1253-57.
70. Nakamura Y, Masuda O, Takano T. Decrease of tissue angiotensin-1-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotechnol Biochem 1996; 60:488-89.
71. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996;64:767-771.
72. Sawada H, Furushiro M, Hirai K, Motoike M. Watanabe T, Yokokura T. Purification and characterization of an antihypertensive compound from Lactobacillus casei. Agric Biol Chem 1990;54:3211-3219.
73. Sanders ME, Walker DC, Walker KM, et al. Performance of commercial cultures in fluid milk applications. J Dairy Science 1996;79:943-55.
74. Salminen SJ, Donahue DC. Safety assessment of Lactobacillus strain GG (ATCC 53103). Nutr Today 1996;31:32S-34S.
75. Saxelin M. Lactobacillus GG - a human probiotic strain with thorough clinical documentation. Food Rev Int 1997;13:293-313.
76. Sanders ME. Development of consumer probiotics for the US market. Br J Nutr 1998;80(Suppl 2):S213-218.